홈/주식/OMER

OMER

USD

Omeros Corporation Common Stock

$6.730-0.330 (-4.674%)

실시간 가격

Healthcare

생명공학

미국

가격 차트

Loading Chart...

핵심 지표

시장 지표

기업 기본 정보

거래 통계

시장 지표

시가

$7.060

고가

$7.240

저가

$6.710

거래량

1.29M

기업 기본 정보

시가총액

458.0M

산업

생명공학

국가

United States

거래 통계

평균 거래량

3.30M

거래소

NGM

통화

USD

52주 범위

저가 $2.95현재가 $6.730고가 $13.6

관련 뉴스

2025년 10월 15일 · 오후 12:34

Reuters

Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push

Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 billion for the U.S.-based company's experimental drug, which is being developed for rare blood and kidney disorders, they said on Wednesday.

Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push

2025년 10월 15일 · 오후 12:30

GlobeNewswire

Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros' clinical-stage MASP-3 inhibitor zaltenibart (OMS906)

Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk's Rare Disease portfolioOmeros is eligible to receive 340 million US dollars in upfront and near-term

Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros' clinical-stage MASP-3 inhibitor zaltenibart (OMS906)

관련 주식

MHF

Western Asset Municipal High Income Fund Inc.

NASDAQ

Finance/Investo...

TALKW

Talkspace Inc. Warrant

NASDAQ

Medical/Nursing...

AGNCN

AGNC Investment Corp. Depositary Shares Each Representing a 1/1000th Interest in a Share of 7.00% Series C Fixed-To-Floating Rate Cumulative Redeemable Preferred Stock

NASDAQ

부동산 투자 신탁